Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:MONEXT50Healthcare
Clear all filters
Buy Granules India; target of Rs 820: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Granules India; target of Rs 820: Motilal Oswal

Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.

GRANULESMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal

Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1730 in its research report dated June 01, 2026.

IPCALABMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal

Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.

GLENMARKMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Mankind Pharma; target of Rs 2640: Motilal Oswal

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.

MANKINDMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Piramal Pharma; target of Rs 190: Motilal Oswal

Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPPLPHARMASPARCFinancial ServicesHealthcare
Buy Star Health; target of Rs 640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Star Health; target of Rs 640: Motilal Oswal

Motilal Oswal is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 640 in its research report dated April 29, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARSTARHEALTHFinancial ServicesHealthcare
Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June
positive
Moneycontrol NaNd ago

Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June

Stocks to Watch, 09 June: Stocks like NLC India, IRB Infrastructure Developers, Panacea Biotec, Grasim Industries, HCL Technologies, Rail Vikas Nigam, JNK India, Motilal Oswal Financial Services, and NRB Bearings will be in focus on June 9.

BHARTIARTLFOCUSGRASIMHCLTECHIDEAIRBJMFINANCILJNKINDIAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENIBLNLCINDIAPANACEABIORVNLCapital GoodsConstruction
HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings
positive
Moneycontrol NaNd ago

HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings

Motilal Oswal Healthcare Foundation, and Motilal Oswal Foundation were sellers in Motilal Oswal Financial Services shares.

HCGHCG-REHDFCLIFEHEALTHCAREHEALTHYJMFINANCILMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENIBLCapital GoodsFinancial Services
PSL offloads 0.6% stake in Sun Pharma Advanced Research, Motilal Oswal buys additional 0.7% stake in Adisoft
positive
Moneycontrol NaNd ago

PSL offloads 0.6% stake in Sun Pharma Advanced Research, Motilal Oswal buys additional 0.7% stake in Adisoft

Sun Pharma Advanced Research Company shares fell 3.72 percent to Rs 143.04 amid high volumes

ADISOFTMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCCapital GoodsFinancial Services
Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal

Motilal Oswal is bullish on Dr Agarwals Health Care recommended buy rating on the stock with a target price of Rs 610 in its research report dated Jun 05, 2026.

AGARWALEYEAMRUTANJANMEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPGHHZOTAFast Moving Consumer GoodsFinancial Services
Buy Rubicon Research; target of Rs 955: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Rubicon Research; target of Rs 955: Motilal Oswal

Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 955 in its research report dated April 15, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUERUBICONFinancial ServicesHealthcare
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Laurus Labs; target of Rs 1280: Motilal Oswal

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated March 19, 2026.

LAURUSLABSMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Prev
566